Seminars in Hematology
Volume 45, Issue 2 , Pages 126-132, April 2008

Novel and Engineered Anti–B-Cell Monoclonal Antibodies for Non-Hodgkin’s Lymphoma

Center for Lymphoma and Myeloma, Division of Hematology-Oncology, Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by a Terry Fox fellowship from the National Cancer Institute of Canada (P.M), and by the Lymphoma Foundation (J.P.L.).

PII: S0037-1963(08)00008-5

doi:10.1053/j.seminhematol.2008.02.007

Seminars in Hematology
Volume 45, Issue 2 , Pages 126-132, April 2008

Article Tools

* Image Usage & Resolution